Liposomal co-delivery of daptomycin and clarithromycin at an optimized ratio for treatment of methicillin-resistant<i>Staphylococcus aureus</i>infection
Liposomal co-delivery of daptomycin and clarithromycin at an optimized ratio for treatment of methicillin-resistant<i>Staphylococcus aureus</i>infection is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Liposomal co-delivery of daptomycin and clarithromycin at an optimized ratio for treatment of methicillin-resistant<i>Staphylococcus aureus</i>infection have?
Liposomal co-delivery of daptomycin and clarithromycin at an optimized ratio for treatment of methicillin-resistant<i>Staphylococcus aureus</i>infection has 62 citations in the OpenAlex counts ScholarIQ stores.
When was Liposomal co-delivery of daptomycin and clarithromycin at an optimized ratio for treatment of methicillin-resistant<i>Staphylococcus aureus</i>infection published?
Liposomal co-delivery of daptomycin and clarithromycin at an optimized ratio for treatment of methicillin-resistant<i>Staphylococcus aureus</i>infection has 2014 year in the ScholarIQ index.
What is the open-access status of Liposomal co-delivery of daptomycin and clarithromycin at an optimized ratio for treatment of methicillin-resistant<i>Staphylococcus aureus</i>infection?
Liposomal co-delivery of daptomycin and clarithromycin at an optimized ratio for treatment of methicillin-resistant<i>Staphylococcus aureus</i>infection has bronze oa status in the ScholarIQ index.
What is the DOI of Liposomal co-delivery of daptomycin and clarithromycin at an optimized ratio for treatment of methicillin-resistant<i>Staphylococcus aureus</i>infection?
The DOI for Liposomal co-delivery of daptomycin and clarithromycin at an optimized ratio for treatment of methicillin-resistant<i>Staphylococcus aureus</i>infection is on the source record.
What is the PMID of Liposomal co-delivery of daptomycin and clarithromycin at an optimized ratio for treatment of methicillin-resistant<i>Staphylococcus aureus</i>infection?
The PMID for Liposomal co-delivery of daptomycin and clarithromycin at an optimized ratio for treatment of methicillin-resistant<i>Staphylococcus aureus</i>infection is on the source record.
What is the OpenAlex record for Liposomal co-delivery of daptomycin and clarithromycin at an optimized ratio for treatment of methicillin-resistant<i>Staphylococcus aureus</i>infection?
The OpenAlex for Liposomal co-delivery of daptomycin and clarithromycin at an optimized ratio for treatment of methicillin-resistant<i>Staphylococcus aureus</i>infection is on the source record.